Your AI pilots worked. The proof of concepts checked every box. Finance loved the projections, IT approved the security protocols, and the board nodded along. Then nothing happened. If this sounds familiar, you’re not alone. Walk the exhibit halls at any major pharma conference this year and you’ll hear the same story repeated in different […]
If you have ever been part of a BI migration project, you know the pattern: it starts with a clear plan, a reasonable timeline, and strong executive sponsorship. Six months later, you are behind schedule, over budget, and fielding complaints from business users about dashboards that do not match the originals. BI migration is one […]
Medical affairs has long been one of the least analytically mature functions in pharma. While commercial teams have invested heavily in CRM analytics, field force optimization, and marketing mix modeling, medical affairs teams often rely on basic activity reports and manual literature review. This is changing rapidly. AI is transforming medical affairs from a reporting […]
Medication adherence remains one of the most stubborn challenges in healthcare. Across therapeutic areas, approximately 50 percent of patients do not take their medications as prescribed. For pharma companies, this represents billions in lost revenue and, more importantly, millions of patients who are not receiving the full benefit of their therapy. The solution is not […]
Every pharma commercial leader talks about omnichannel. But most organizations are still measuring channels in isolation – digital over here, field force over there, medical engagement somewhere else entirely. The result is a fragmented view of HCP engagement that makes it impossible to optimize the total investment. True omnichannel analytics is not about measuring more […]
